albuterol has been researched along with Atopic Hypersensitivity in 39 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fourteen atopic patients with mild-to-moderate asthma (forced expiratory volume in 1 second of 76%) completed a double-blind, randomized, crossover study consisting of 3-week treatment blocks of either fluticasone propionate-salmeterol, 250 microg twice daily, or fluticasone propionate alone, 250 microg twice daily, in conjunction with either fexofenadine, 180 mg once daily, or matched placebo." | 9.11 | Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. ( Fardon, TC; Hodge, MR; Lee, DK; Lipworth, BJ, 2005) |
| "We have recently demonstrated that a 2-week course of inhaled albuterol 200 micrograms four times daily caused a near doubling of the allergen-induced early asthmatic response." | 9.08 | Regular use of inhaled albuterol and the allergen-induced late asthmatic response. ( Bhagat, R; Cockcroft, DW; O'Byrne, PM; Swystun, VA, 1995) |
| "4 mg azelastine administered orally on airway responsiveness, skin prick testing, daily peak expiratory flow rates and symptoms of asthma was compared with placebo in a 7 week double-blind, parallel group study of 24 patients with extrinsic asthma." | 9.06 | A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness. ( Aurich, R; Davies, RJ; Gould, CA; Ollier, S, 1988) |
| "Baseline survey data, salivary cotinine levels, and allergen specific IgE serologic test results were obtained from children with uncontrolled asthma enrolled in a randomized clinical trial of a behavioral education environmental control intervention." | 5.30 | Characteristics of inner-city children with life-threatening asthma. ( Bollinger, ME; Butz, A; Lewis-Land, C; Morphew, T; Mudd, S; Tsoukleris, M, 2019) |
| "Fourteen atopic patients with mild-to-moderate asthma (forced expiratory volume in 1 second of 76%) completed a double-blind, randomized, crossover study consisting of 3-week treatment blocks of either fluticasone propionate-salmeterol, 250 microg twice daily, or fluticasone propionate alone, 250 microg twice daily, in conjunction with either fexofenadine, 180 mg once daily, or matched placebo." | 5.11 | Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. ( Fardon, TC; Hodge, MR; Lee, DK; Lipworth, BJ, 2005) |
| "These data demonstrate that asthma duration is associated with lower lung function, greater methacholine responsiveness, more asthma symptomatology, and greater use of as-needed albuterol, which are all measures of asthma severity." | 5.09 | Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP) ( Dawson, C; Weiss, S; Zeiger, RS, 1999) |
| "We have recently demonstrated that a 2-week course of inhaled albuterol 200 micrograms four times daily caused a near doubling of the allergen-induced early asthmatic response." | 5.08 | Regular use of inhaled albuterol and the allergen-induced late asthmatic response. ( Bhagat, R; Cockcroft, DW; O'Byrne, PM; Swystun, VA, 1995) |
| " The aim of the study was to determine the carbachol and albuterol responsiveness in treated and untreated asthmatic and allergic children exposed to environmental tobacco smoke assessed by urinary cotinine measurements." | 5.08 | Possible interaction between exposure to environmental tobacco smoke and therapy in children with asthma. ( Badier, M; Bruguerolle, B; Dubus, JC; Guillot, C; Oddoze, C, 1998) |
| "4 mg azelastine administered orally on airway responsiveness, skin prick testing, daily peak expiratory flow rates and symptoms of asthma was compared with placebo in a 7 week double-blind, parallel group study of 24 patients with extrinsic asthma." | 5.06 | A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness. ( Aurich, R; Davies, RJ; Gould, CA; Ollier, S, 1988) |
| "Chronic obstructive pulmonary disease (COPD) is characterised by limited bronchial reversibility and chronic neutrophilic inflammation." | 2.71 | Reversibility to a beta2-agonist in COPD: relationship to atopy and neutrophil activation. ( Lötvall, J; Malakauskas, K; Sakalauskas, R; Sitkauskiene, B, 2003) |
| "Although beta2-adrenoceptor agonists are widely used in the treatment of asthma, a number of studies have suggested that their long-term use may exacerbate the condition." | 2.69 | Effect of systemic beta-agonist therapy on IgE production in allergic subjects in vivo. ( Beasely, R; Church, M; Corne, JM; Howarth, PH; Lau, LC; Linaker, CH; Merrett, T, 1998) |
| "Pretreatment with albuterol, cromolyn, and a combination of albuterol and cromolyn 30 minutes before ETS exposure significantly diminished airway reactivity to ETS." | 2.67 | Asthmatic responses to passive cigarette smoke: persistence of reactivity and effect of medications. ( Lehrer, SB; Menon, PK; Rando, RJ; Salvaggio, JE; Stankus, RP, 1991) |
| "Propranolol was inhaled 20 minutes after an antigen challenge in passively sensitized, anesthetized, and artificially ventilated guinea pigs." | 1.30 | Difference in bronchoprotective effects of bronchodilators on postallergic propranolol-induced bronchoconstriction. ( Fujimura, M; Ishiura, Y; Matsuda, T; Mizuhashi, K; Myou, S, 1999) |
| "No effects of treatment on cough frequency were demonstrated." | 1.27 | Night cough and general practice research. ( Howie, JG; Paxton, FM; Toop, LJ, 1986) |
| " The development of resistance was assessed from salbutamol dose-response studies in which the airway response was measured as specific airway conductance (sGaw)." | 1.26 | Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. ( Harvey, JE; Tattersfield, AE, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (30.77) | 18.7374 |
| 1990's | 14 (35.90) | 18.2507 |
| 2000's | 10 (25.64) | 29.6817 |
| 2010's | 3 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, C | 1 |
| Liu, J | 1 |
| Yang, H | 1 |
| Xiang, L | 1 |
| Zhao, S | 1 |
| Bollinger, ME | 1 |
| Butz, A | 1 |
| Tsoukleris, M | 1 |
| Lewis-Land, C | 1 |
| Mudd, S | 1 |
| Morphew, T | 1 |
| Fujimura, M | 2 |
| Miyagawa, N | 1 |
| Iwasaki, H | 1 |
| Kato, T | 1 |
| Tanaka, M | 1 |
| Shibata, T | 1 |
| Wakitani, K | 1 |
| Heymann, WR | 1 |
| Silvestri, M | 1 |
| Sabatini, F | 1 |
| Sale, R | 1 |
| Defilippi, AC | 1 |
| Fregonese, L | 1 |
| Battistini, E | 1 |
| Biraghi, MG | 1 |
| Rossi, GA | 1 |
| Sitkauskiene, B | 1 |
| Sakalauskas, R | 1 |
| Malakauskas, K | 1 |
| Lötvall, J | 1 |
| Marotta, A | 1 |
| Klinnert, MD | 1 |
| Price, MR | 1 |
| Larsen, GL | 1 |
| Liu, AH | 1 |
| Spooner, LM | 1 |
| Olin, JL | 1 |
| Fardon, TC | 1 |
| Lee, DK | 1 |
| Hodge, MR | 1 |
| Lipworth, BJ | 1 |
| Arandelović, M | 1 |
| Stanković, I | 1 |
| Nikolić, M | 1 |
| Bierman, CW | 1 |
| Jolobe, OM | 1 |
| Yamada, Y | 1 |
| Kawai, T | 1 |
| Onaka, A | 1 |
| Kamo, T | 1 |
| Ajisawa, A | 1 |
| Harvey, JE | 1 |
| Tattersfield, AE | 1 |
| Michel, FB | 1 |
| Bousquet, J | 1 |
| Greillier, P | 1 |
| Robinet-Levy, M | 1 |
| Coulomb, Y | 1 |
| Ormerod, LP | 1 |
| Thomson, RA | 1 |
| Anderson, CM | 1 |
| Stableforth, DE | 1 |
| Cockcroft, DW | 1 |
| O'Byrne, PM | 1 |
| Swystun, VA | 1 |
| Bhagat, R | 1 |
| Fedoseev, GB | 1 |
| Emel'ianov, AV | 1 |
| Sinitsina, TM | 1 |
| Goncharova, VA | 1 |
| Poriadin, GV | 1 |
| Salmasi, ZhM | 1 |
| Busarova, EA | 1 |
| Zhuravleva, NE | 1 |
| Choy, AC | 1 |
| Patterson, R | 1 |
| Patterson, DR | 1 |
| Grammer, LC | 1 |
| Greenberger, PA | 1 |
| McGrath, KG | 1 |
| Harris, KE | 1 |
| Di Lorenzo, G | 1 |
| Morici, G | 1 |
| Norrito, F | 1 |
| Mansueto, P | 1 |
| Melluso, M | 1 |
| Purello D'Ambrosio, F | 1 |
| Barbagallo Sangiorgi, G | 1 |
| Dubus, JC | 1 |
| Oddoze, C | 1 |
| Badier, M | 1 |
| Guillot, C | 1 |
| Bruguerolle, B | 1 |
| Corne, JM | 1 |
| Linaker, CH | 1 |
| Howarth, PH | 1 |
| Lau, LC | 1 |
| Merrett, T | 1 |
| Beasely, R | 1 |
| Church, M | 1 |
| Zeiger, RS | 1 |
| Dawson, C | 1 |
| Weiss, S | 1 |
| Mizuhashi, K | 1 |
| Ishiura, Y | 1 |
| Myou, S | 1 |
| Matsuda, T | 1 |
| Chavasse, RJ | 1 |
| Bastian-Lee, Y | 1 |
| Richter, H | 1 |
| Hilliard, T | 1 |
| Seddon, P | 1 |
| McKenzie, SA | 1 |
| Bridge, PD | 1 |
| Healy, MJ | 1 |
| Kallenbach, J | 1 |
| Joffe, BI | 1 |
| Zwi, S | 1 |
| Seftel, HC | 1 |
| Taylor, IK | 1 |
| O'Shaughnessy, KM | 1 |
| Choudry, NB | 1 |
| Adachi, M | 1 |
| Palmer, JB | 1 |
| Fuller, RW | 1 |
| Menon, PK | 1 |
| Stankus, RP | 1 |
| Rando, RJ | 1 |
| Salvaggio, JE | 1 |
| Lehrer, SB | 1 |
| Frans, A | 1 |
| Garin, P | 1 |
| Van den Eeckhaudt, J | 1 |
| Schauer, U | 1 |
| Dippel, E | 1 |
| Gieler, U | 1 |
| Bräuer, J | 1 |
| Jung, T | 1 |
| Heymanns, J | 1 |
| Rieger, CH | 1 |
| Malo, JL | 1 |
| Ghezzo, H | 1 |
| L'Archevêque, J | 1 |
| Cartier, A | 1 |
| Warren, JB | 1 |
| Pixley, FJ | 1 |
| Dollery, CT | 1 |
| Gould, CA | 1 |
| Ollier, S | 1 |
| Aurich, R | 1 |
| Davies, RJ | 1 |
| Marazzini, L | 1 |
| Bozzoni, M | 1 |
| Mastropasqua, B | 1 |
| Pelucchi, A | 1 |
| Gabrione, M | 1 |
| Toop, LJ | 1 |
| Howie, JG | 1 |
| Paxton, FM | 1 |
| Cobos Barroso, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Asthma Express Intervention to Bridge Emergency to Primary Care for High Risk Children With Asthma[NCT01981564] | 222 participants (Actual) | Interventional | 2013-04-15 | Completed | |||
| Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma?[NCT01239199] | 86 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| Childhood Asthma Management Program[NCT00000575] | Phase 3 | 1,041 participants (Actual) | Interventional | 1991-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of emergency department visits for asthma in the past 3 months (NCT01981564)
Timeframe: 3 months
| Intervention | visits (Mean) |
|---|---|
| Asthma Express Intervention | 0.64 |
| Standard Asthma Education Control Group | 0.62 |
Symptom days for asthma during past 14 days (NCT01981564)
Timeframe: 3 months
| Intervention | symptom days over past 14 days (Mean) |
|---|---|
| Asthma Express Intervention | 6.24 |
| Standard ASthma Education Control Group | 4.82 |
Bronchial responsiveness to serial concentrations of inhaled methacholine solution (mg/ml) as measured by serial ratios of follow-up to baseline FEV1 (forced volume of air expired from the lungs in one second). A dose-response curve is calculated from the serial ratios in relation to the serial concentrations to determine PC20, the concentration associated with a 20% drop from baseline in FEV1; this PC20 is the outcome measure with units mg/ml of methacholine. (NCT00000575)
Timeframe: 4-6 years from baseline
| Intervention | mg/ml of methacholine (Geometric Mean) |
|---|---|
| 1 Budesonide | 3.0 |
| 2 Nedocromil | 1.8 |
| 3 Placebo | 1.9 |
Change from baseline proportion of days without asthma symptoms or other asthma related events to proportion of days during the 4-6 years of follow-up. Asthma free days were determined from daily asthma diaries kept from baseline to the end of treatment, 4-6 years later. (NCT00000575)
Timeframe: 4-6 years from baseline
| Intervention | days per month (Mean) |
|---|---|
| 1 Budesonide | 11.3 |
| 2 Nedocromil | 9.3 |
| 3 Placebo | 9.3 |
Change in standing height from baseline to end of treatment. Standing height is measured three times without shoes using a calibrated Harpenden stadiometer; the average of the three repeated heights to the nearest 0.1 cm is the height measure at either baseline or end of treatment. (NCT00000575)
Timeframe: 4-6 years from baseline
| Intervention | cm (Mean) |
|---|---|
| 1 Budesonide | 22.7 |
| 2 Nedocromil | 23.7 |
| 3 Placebo | 23.8 |
Counts of deaths from asthma. (NCT00000575)
Timeframe: 4-6 years from baseline
| Intervention | participants (Number) |
|---|---|
| 1 Budesonide | 0 |
| 2 Nedocromil | 1 |
| 3 Placebo | 0 |
Counts during the period of treatment (4-6 years) of visits to emergency rooms or equivalent urgent care settings for asthma treatment. (NCT00000575)
Timeframe: 4-6 years from baseline
| Intervention | rate per 100 person years (Number) |
|---|---|
| 1 Budesonide | 12 |
| 2 Nedocromil | 16 |
| 3 Placebo | 22 |
Change in FEV1 % of predicted, post-bronchodilator use, from baseline to the end of treatment (4-6 years after randomization). Percent predicted determined from three separate published sets of reference equations for white, black, and Hispanic children - see NEJM 343: 1054-1062, 2000 for more details and references. (NCT00000575)
Timeframe: At the end of treatment, 4-6 years from baseline assessment
| Intervention | percentage of predicted value (Mean) |
|---|---|
| 1 Budesonide | 0.6 |
| 2 Nedocromil | -0.5 |
| 3 Placebo | -0.1 |
Change in total score on the Children's Depression Inventory from baseline to the end of treatment, 4-6 years later. The total score ranges from 0-54 with higher scores indicating greater levels of depression. (NCT00000575)
Timeframe: 4-6 years from baseline
| Intervention | units on a scale (Mean) |
|---|---|
| 1 Budesonide | -3.2 |
| 2 Nedocromil | -1.8 |
| 3 Placebo | -2.2 |
2 reviews available for albuterol and Atopic Hypersensitivity
| Article | Year |
|---|---|
[Causes of prolonged and chronic cough].
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Asthma; Chronic Disease; Clenbuterol; Cough; Dr | 2008 |
[Isolated cough and bronchial asthma].
Topics: Adolescent; Adult; Aged; Albuterol; Asthma; Beclomethasone; Bronchial Provocation Tests; Chronic Dis | 1991 |
14 trials available for albuterol and Atopic Hypersensitivity
| Article | Year |
|---|---|
Characteristics of inner-city children with life-threatening asthma.
Topics: Adult; Albuterol; Allergens; Anti-Asthmatic Agents; Asthma; Caregivers; Child; Child, Preschool; Cot | 2019 |
Reversibility to a beta2-agonist in COPD: relationship to atopy and neutrophil activation.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Dose-Response Relationship, Drug; Eosinoph | 2003 |
Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adult; Alb | 2005 |
Swimming and persons with mild persistant asthma.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Beclomethasone; Bronchial Hyperreactivity; Femal | 2007 |
Regular use of inhaled albuterol and the allergen-induced late asthmatic response.
Topics: Administration, Inhalation; Adult; Albuterol; Allergens; Asthma; Cross-Over Studies; Double-Blind Me | 1995 |
Comparison of the effects of salmeterol and salbutamol on clinical activity and eosinophil cationic protein serum levels during the pollen season in atopic asthmatics.
Topics: Adult; Albuterol; Asthma; Blood Proteins; Cell Count; Cross-Over Studies; Eosinophil Granule Protein | 1995 |
Possible interaction between exposure to environmental tobacco smoke and therapy in children with asthma.
Topics: Adolescent; Albuterol; Asthma; Biomarkers; Bronchial Hyperreactivity; Bronchial Provocation Tests; B | 1998 |
Effect of systemic beta-agonist therapy on IgE production in allergic subjects in vivo.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Double-Blind Method; Female; Humans; Hypersensit | 1998 |
Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP)
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Allergens; Anti-Asthmatic | 1999 |
Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP)
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Allergens; Anti-Asthmatic | 1999 |
Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP)
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Allergens; Anti-Asthmatic | 1999 |
Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP)
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Allergens; Anti-Asthmatic | 1999 |
Inhaled salbutamol for wheezy infants: a randomised controlled trial.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Metho | 2000 |
A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion.
Topics: Adrenergic beta-Agonists; Albuterol; Allergens; Asthma; Bronchial Hyperreactivity; Bronchial Provoca | 1992 |
Asthmatic responses to passive cigarette smoke: persistence of reactivity and effect of medications.
Topics: Adult; Albuterol; Asthma; Bronchial Provocation Tests; Cromolyn Sodium; Female; Humans; Hypersensiti | 1991 |
Importance of beta 2-adrenoceptor stimulation in the suppression of intradermal antigen challenge by adrenaline.
Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Antigens; Epinephrine; Humans; Hypersensitivity, Imme | 1989 |
A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness.
Topics: Adult; Albuterol; Asthma; Bronchial Provocation Tests; Double-Blind Method; Female; Histamine H1 Ant | 1988 |
23 other studies available for albuterol and Atopic Hypersensitivity
| Article | Year |
|---|---|
Mycoplasma pneumoniae-Associated Bronchiolitis Obliterans Following Acute Bronchiolitis.
Topics: Albuterol; Asthma; Bronchiolitis; Bronchiolitis Obliterans; Child; Child, Preschool; Female; Humans; | 2017 |
Two pharmacological phases in antigen-induced immediate airway response in rats.
Topics: Administration, Inhalation; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Agonists; Albutero | 2008 |
Caregiver hypersensitivity.
Topics: Administration, Inhalation; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Caregivers; Drug | 2010 |
Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals.
Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Asthma; Breath Tests; Bronchodilator Agents | 2003 |
Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma.
Topics: Airway Resistance; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchodilator Agents; Child, Presc | 2003 |
Paradoxical bronchoconstriction with albuterol administered by metered-dose inhaler and nebulizer solution.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Bronchocon | 2005 |
A comparison of late reactions to antigen and exercise.
Topics: Albuterol; Antigens; Asthma; Asthma, Exercise-Induced; Bronchial Provocation Tests; Chemotactic Fact | 1984 |
Impaired atropine responsiveness in asthma: role of atopy.
Topics: Adult; Aged; Albuterol; Asthma; Atropine; Atropine Derivatives; Female; Humans; Hypersensitivity, Im | 1983 |
[Influence of sympathomimetic drugs on immediate intradermal reactions induced by allergens].
Topics: Adult; Albuterol; Asthma; Clenbuterol; Ethanolamines; Humans; Hypersensitivity, Immediate; Intraderm | 1984 |
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects.
Topics: Adolescent; Adult; Airway Resistance; Albuterol; Asthma; Bronchi; Bronchial Provocation Tests; Dose- | 1982 |
Comparison of cord blood immunoglobulin E concentrations and maternal allergy for the prediction of atopic diseases in infancy.
Topics: Albuterol; Animals; Cattle; Female; Fetal Blood; Follow-Up Studies; Humans; Hypersensitivity; Hypers | 1980 |
Reversible airway obstruction in cystic fibrosis.
Topics: Adolescent; Age Factors; Airway Obstruction; Albuterol; Asthma; Child; Child, Preschool; Cystic Fibr | 1980 |
[The therapeutic potentials of Ditec in bronchial asthma patients].
Topics: Adult; Aerosols; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cromolyn | 1995 |
[Corrective effect of the Russian bronchodilator preparations saventol and troventol on the lymphocyte regulatory function of atopic bronchial asthma patients in vitro].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Albuterol; Asthma; Atropine Derivatives; Bronchodilator A | 1994 |
Undifferentiated somatoform idiopathic anaphylaxis: nonorganic symptoms mimicking idiopathic anaphylaxis.
Topics: Adult; Albuterol; Anaphylaxis; Diagnosis, Differential; Female; Humans; Hydroxyzine; Hypersensitivit | 1995 |
Difference in bronchoprotective effects of bronchodilators on postallergic propranolol-induced bronchoconstriction.
Topics: Airway Resistance; Albuterol; Aminophylline; Animals; Atropine; Bronchi; Bronchial Hyperreactivity; | 1999 |
Airway resistance and atopy in preschool children with wheeze and cough.
Topics: Airway Resistance; Albuterol; Asthma; Bronchodilator Agents; Child, Preschool; Cough; Female; Humans | 2000 |
Metabolic and cardiovascular effects of salbutamol in atopic subjects with and without asthma.
Topics: Adult; Albuterol; Asthma; Blood Glucose; Fatty Acids, Nonesterified; Female; Forced Expiratory Volum | 1979 |
T cell receptor gamma delta bearing cells are decreased in the peripheral blood of patients with atopic diseases.
Topics: Adolescent; Adult; Albuterol; Antibodies, Monoclonal; Asthma; Beclomethasone; CD8 Antigens; Child; C | 1991 |
Late asthmatic reactions to occupational sensitizing agents: frequency of changes in nonspecific bronchial responsiveness and of response to inhaled beta 2-adrenergic agent.
Topics: Albuterol; Asthma; Bronchi; Bronchial Provocation Tests; Forced Expiratory Volume; Humans; Hypersens | 1990 |
The effect of adrenoceptor agonists and antagonists on histamine-induced wheal response in the skin of normal subjects and atopic patients.
Topics: Adrenergic Antagonists; Adult; Albuterol; Histamine; Humans; Hypersensitivity, Delayed; Hypersensiti | 1988 |
Night cough and general practice research.
Topics: Albuterol; Child; Child, Preschool; Cough; Humans; Hypersensitivity, Immediate; Prospective Studies; | 1986 |
[Bronchial hyperreactivity to pneumo-allergens].
Topics: Adolescent; Albuterol; Allergens; Asthma; Beclomethasone; Bronchi; Bronchial Provocation Tests; Bron | 1985 |